Molecular epidemiology and HIV-1 variant evolution in Poland between 2015 and 2019
Abstract The occurrence of HIV-1 subtypes differs worldwide and within Europe, with non-B variants mainly found across different exposure groups. In this study, we investigated the distribution and temporal trends in HIV-1 subtype variability across Poland between 2015 and 2019. Sequences of the pol...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/57ebb405ba7b40c8803ef69e003bae93 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:57ebb405ba7b40c8803ef69e003bae93 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:57ebb405ba7b40c8803ef69e003bae932021-12-02T17:08:35ZMolecular epidemiology and HIV-1 variant evolution in Poland between 2015 and 201910.1038/s41598-021-96125-w2045-2322https://doaj.org/article/57ebb405ba7b40c8803ef69e003bae932021-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-96125-whttps://doaj.org/toc/2045-2322Abstract The occurrence of HIV-1 subtypes differs worldwide and within Europe, with non-B variants mainly found across different exposure groups. In this study, we investigated the distribution and temporal trends in HIV-1 subtype variability across Poland between 2015 and 2019. Sequences of the pol gene fragment from 2518 individuals were used for the analysis of subtype prevalence. Subtype B was dominant (n = 2163, 85.90%). The proportion of subtype B-infected individuals decreased significantly, from 89.3% in 2015 to 80.3% in 2019. This was related to the increasing number of subtype A infections. In 355 (14.10%) sequences, non-B variants were identified. In 65 (2.58%) samples, recombinant forms (RFs) were noted. Unique recombinant forms (URFs) were found in 30 (1.19%) sequences. Three A/B recombinant clusters were identified of which two were A6/B mosaic viruses not previously described. Non-B clades were significantly more common among females (n = 81, 22.8%, p = 0.001) and heterosexually infected individuals (n = 45, 32.4%, p = 0.0031). The predominance of subtype B is evident, but the variability of HIV-1 in Poland is notable. Almost half of RFs (n = 65, 2.58%) was comprised of URFs (n = 30, 1.19%); thus those forms were common in the analyzed population. Hence, molecular surveillance of identified variants ensures recognition of HIV-1 evolution in Poland.Karol SerwinAnna UrbańskaKaja ScheibeMagdalena Witak-JędraMaria JankowskaMaria HlebowiczMonika Bociąga-JasikAnna Kalinowska-NowakMartyna BiałaHubert CiepłuchaWładysław ŁojewskiAnita OlczakElżbieta JabłonowskaAldona Kowalczuk-KotBłażej RozpłochowskiAdam WitorMiłosz ParczewskiNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-17 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Karol Serwin Anna Urbańska Kaja Scheibe Magdalena Witak-Jędra Maria Jankowska Maria Hlebowicz Monika Bociąga-Jasik Anna Kalinowska-Nowak Martyna Biała Hubert Ciepłucha Władysław Łojewski Anita Olczak Elżbieta Jabłonowska Aldona Kowalczuk-Kot Błażej Rozpłochowski Adam Witor Miłosz Parczewski Molecular epidemiology and HIV-1 variant evolution in Poland between 2015 and 2019 |
description |
Abstract The occurrence of HIV-1 subtypes differs worldwide and within Europe, with non-B variants mainly found across different exposure groups. In this study, we investigated the distribution and temporal trends in HIV-1 subtype variability across Poland between 2015 and 2019. Sequences of the pol gene fragment from 2518 individuals were used for the analysis of subtype prevalence. Subtype B was dominant (n = 2163, 85.90%). The proportion of subtype B-infected individuals decreased significantly, from 89.3% in 2015 to 80.3% in 2019. This was related to the increasing number of subtype A infections. In 355 (14.10%) sequences, non-B variants were identified. In 65 (2.58%) samples, recombinant forms (RFs) were noted. Unique recombinant forms (URFs) were found in 30 (1.19%) sequences. Three A/B recombinant clusters were identified of which two were A6/B mosaic viruses not previously described. Non-B clades were significantly more common among females (n = 81, 22.8%, p = 0.001) and heterosexually infected individuals (n = 45, 32.4%, p = 0.0031). The predominance of subtype B is evident, but the variability of HIV-1 in Poland is notable. Almost half of RFs (n = 65, 2.58%) was comprised of URFs (n = 30, 1.19%); thus those forms were common in the analyzed population. Hence, molecular surveillance of identified variants ensures recognition of HIV-1 evolution in Poland. |
format |
article |
author |
Karol Serwin Anna Urbańska Kaja Scheibe Magdalena Witak-Jędra Maria Jankowska Maria Hlebowicz Monika Bociąga-Jasik Anna Kalinowska-Nowak Martyna Biała Hubert Ciepłucha Władysław Łojewski Anita Olczak Elżbieta Jabłonowska Aldona Kowalczuk-Kot Błażej Rozpłochowski Adam Witor Miłosz Parczewski |
author_facet |
Karol Serwin Anna Urbańska Kaja Scheibe Magdalena Witak-Jędra Maria Jankowska Maria Hlebowicz Monika Bociąga-Jasik Anna Kalinowska-Nowak Martyna Biała Hubert Ciepłucha Władysław Łojewski Anita Olczak Elżbieta Jabłonowska Aldona Kowalczuk-Kot Błażej Rozpłochowski Adam Witor Miłosz Parczewski |
author_sort |
Karol Serwin |
title |
Molecular epidemiology and HIV-1 variant evolution in Poland between 2015 and 2019 |
title_short |
Molecular epidemiology and HIV-1 variant evolution in Poland between 2015 and 2019 |
title_full |
Molecular epidemiology and HIV-1 variant evolution in Poland between 2015 and 2019 |
title_fullStr |
Molecular epidemiology and HIV-1 variant evolution in Poland between 2015 and 2019 |
title_full_unstemmed |
Molecular epidemiology and HIV-1 variant evolution in Poland between 2015 and 2019 |
title_sort |
molecular epidemiology and hiv-1 variant evolution in poland between 2015 and 2019 |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/57ebb405ba7b40c8803ef69e003bae93 |
work_keys_str_mv |
AT karolserwin molecularepidemiologyandhiv1variantevolutioninpolandbetween2015and2019 AT annaurbanska molecularepidemiologyandhiv1variantevolutioninpolandbetween2015and2019 AT kajascheibe molecularepidemiologyandhiv1variantevolutioninpolandbetween2015and2019 AT magdalenawitakjedra molecularepidemiologyandhiv1variantevolutioninpolandbetween2015and2019 AT mariajankowska molecularepidemiologyandhiv1variantevolutioninpolandbetween2015and2019 AT mariahlebowicz molecularepidemiologyandhiv1variantevolutioninpolandbetween2015and2019 AT monikabociagajasik molecularepidemiologyandhiv1variantevolutioninpolandbetween2015and2019 AT annakalinowskanowak molecularepidemiologyandhiv1variantevolutioninpolandbetween2015and2019 AT martynabiała molecularepidemiologyandhiv1variantevolutioninpolandbetween2015and2019 AT hubertciepłucha molecularepidemiologyandhiv1variantevolutioninpolandbetween2015and2019 AT władysławłojewski molecularepidemiologyandhiv1variantevolutioninpolandbetween2015and2019 AT anitaolczak molecularepidemiologyandhiv1variantevolutioninpolandbetween2015and2019 AT elzbietajabłonowska molecularepidemiologyandhiv1variantevolutioninpolandbetween2015and2019 AT aldonakowalczukkot molecularepidemiologyandhiv1variantevolutioninpolandbetween2015and2019 AT błazejrozpłochowski molecularepidemiologyandhiv1variantevolutioninpolandbetween2015and2019 AT adamwitor molecularepidemiologyandhiv1variantevolutioninpolandbetween2015and2019 AT miłoszparczewski molecularepidemiologyandhiv1variantevolutioninpolandbetween2015and2019 |
_version_ |
1718381553442095104 |